Basel, Switzerland

Neil Pegg


 

Average Co-Inventor Count = 13.0

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Neil Pegg

Introduction

Neil Pegg is a prominent inventor based in Basel, Switzerland, known for his significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, Pegg has focused his research on PI3K inhibitor compounds, making strides in the fight against cancer.

Latest Patents

Among his latest innovations are the patents for benzopyran and benzoxepin PI3K inhibitor compounds and their methods of use. These compounds, identified in Formulas I and II, including their stereoisomers, geometric isomers, tautomers, solvates, metabolites, and pharmaceutically acceptable salts, are designed to inhibit lipid kinases, particularly p110 alpha and other isoforms of PI3K. This inhibition offers potential therapeutic avenues for treating cancer and related disorders mediated by lipid kinases. The patents further disclose methods for using these compounds in various settings—be it in vitro, in situ, or in vivo—to diagnose, prevent, or treat such pathological conditions in mammalian cells.

Career Highlights

Neil Pegg has carved out a distinguished career, having worked with renowned companies, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these prominent organizations has undoubtedly contributed to his extensive knowledge and his innovative output within the pharmaceutical industry.

Collaborations

Throughout his career, Pegg has collaborated with talented professionals, such as Steven Huy Do and Richard A Goldsmith. These collaborations have played a crucial role in the successful development of his patents and their applications in combating serious health issues.

Conclusion

Neil Pegg's innovative work, particularly in the realm of PI3K inhibitors, demonstrates his commitment to advancing pharmaceutical research and potentially improving treatment avenues for cancer. With a solid foundation of patents and collaborations, Pegg continues to contribute to the fight against disease through innovation and research excellence.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…